NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…
INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of…
September 03, 2025 17:17 ET | Source: Senseonics Holdings, Inc. CGM commercial operations to transition from Ascensia Diabetes Care to…
This round of capital is the largest raised among deep tech and energy companies since CFS' $1.8 billion Series B…
Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net…